Gyre Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $25,488 | $25,225 | $27,172 | $29,981 |
Gross Profit | 24,530 | 24,455 | 26,193 | 28,733 |
EBITDA | 4,233 | 3,500 | 8,496 | 2,450 |
EBIT | 3,262 | 8,071 | 2,267 | |
Net Income | 5,004 | 3,528 | 7,532 | -52,192 |
Net Change In Cash | 25,488 | 25,225 | 27,172 | 29,981 |
Free Cash Flow | 1,033 | -6,949 | 2,653 | 1,652 |
Cash | 15,866 | 16,097 | 29,785 | 33,509 |
Basic Shares | 102,640 | 104,325 | 102,594 | 76,595 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $113,450 | $794 | $7,338 | $20,948 |
Gross Profit | 108,814 | -4 | -42 | 11,785 |
EBITDA | 20,327 | 10,332 | -87,604 | -57,370 |
EBIT | 19,213 | 9,203 | -87,894 | -57,508 |
Net Income | -92,933 | 2,302 | -87,933 | -55,542 |
Net Change In Cash | 113,450 | 794 | 7,338 | 20,948 |
Free Cash Flow | 17,306 | -38,094 | -84,594 | -55,315 |
Cash | 33,509 | 21,666 | 44,347 | 30,360 |
Basic Shares | 65,831 | 75,686 | 30,640 | 19,179 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.01 |
2024-06-30 | $0.03 |
2024-03-31 | $0.03 |
2023-09-30 | -$1.05 |
